XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Warrants (Tables)
12 Months Ended
Dec. 31, 2021
Warrants  
Schedule of Stockholders’ Equity Note, Warrants or Rights, Activity

A continuity of the Company’s outstanding share purchase warrants for the years ended December 31, 2021 and 2020 is presented below:

 

   Number of
warrants
   Weighted average exercise price 
Outstanding, December 31, 2019   19,389,961   $0.26 
Issued   34,130,133    0.09 
Expired   (17,654,782)   0.25 
Outstanding, December 31, 2020   35,865,312    0.10 
Issued   14,017,663    0.10 
Exercised   (31,270,314)   0.09 
Expired   (10,768,332)   0.13 
Outstanding, December 31, 2021   7,844,329   $0.10 
Schedule of Warrant Outstanding

At December 31, 2021, the Company had the following outstanding share purchase warrants:

 Schedule of Warrant Outstanding

Outstanding     Exercise Price     Expiry Date
  1,000,000       0.16 USD     March 8, 2023
  50,000       0.32 USD     June 6, 2023
  2,576,249       0.08 USD     September 8, 2023
  1,200,000       0.10 USD     September 8, 2023
  2,358,080       0.08 USD     September 8, 2023
  660,000       0.10 USD     September 30, 2023
  7,844,329              
Schedule of Derivative Warrant Liability

The following is a continuity of the Company’s derivative warrant liability:

 Schedule of Derivative Warrant Liability

   Total 
Balance, January 1, 2020  $79,458 
Issued during the period   1,724,114 
Change in fair value of derivative   199,789 
Balance, December 31, 2020  $1,804,572 
Issued during the period   621,500 
Extinguished during the period   (479,535)
Change in fair value of derivative   (1,473,638)
Balance, December 31, 2021  $472,899